Your browser doesn't support javascript.
loading
Early tumor shrinkage and depth of response predict long-term outcome in metastatic colorectal cancer patients treated with first-line chemotherapy plus bevacizumab: results from phase III TRIBE trial by the Gruppo Oncologico del Nord Ovest.
Cremolini, C; Loupakis, F; Antoniotti, C; Lonardi, S; Masi, G; Salvatore, L; Cortesi, E; Tomasello, G; Spadi, R; Zaniboni, A; Tonini, G; Barone, C; Vitello, S; Longarini, R; Bonetti, A; D'Amico, M; Di Donato, S; Granetto, C; Boni, L; Falcone, A.
Affiliation
  • Cremolini C; Unit of Medical Oncology 2, Polo Oncologico, Azienda Ospedaliero-Universitaria Pisana, Istituto Toscano Tumori, Pisa; Unit of Medical Oncology 2, University of Pisa, Pisa.
  • Loupakis F; Unit of Medical Oncology 2, Polo Oncologico, Azienda Ospedaliero-Universitaria Pisana, Istituto Toscano Tumori, Pisa; Unit of Medical Oncology 2, University of Pisa, Pisa.
  • Antoniotti C; Unit of Medical Oncology 2, Polo Oncologico, Azienda Ospedaliero-Universitaria Pisana, Istituto Toscano Tumori, Pisa; Unit of Medical Oncology 2, University of Pisa, Pisa.
  • Lonardi S; Unit of Medical Oncology 1, Istituto Oncologico Veneto, IRCSS, Padova.
  • Masi G; Unit of Medical Oncology 2, Polo Oncologico, Azienda Ospedaliero-Universitaria Pisana, Istituto Toscano Tumori, Pisa; Unit of Medical Oncology 2, University of Pisa, Pisa.
  • Salvatore L; Unit of Medical Oncology 2, Polo Oncologico, Azienda Ospedaliero-Universitaria Pisana, Istituto Toscano Tumori, Pisa; Unit of Medical Oncology 2, University of Pisa, Pisa.
  • Cortesi E; Department of Medical Oncology, University of Rome La Sapienza, Rome.
  • Tomasello G; Division of Medicine and Medical Oncology, Azienda Istituti Ospitalieri, Cremona.
  • Spadi R; Azienda Ospedaliero-Universitaria Città Della Salute e Della Scienza, Turin.
  • Zaniboni A; Department of Medical Oncology, Fondazione Poliambulanza, Brescia.
  • Tonini G; Department of Medical Oncology, University Campus Biomedico, Rome.
  • Barone C; Unit of Medical Oncology, Università Cattolica del Sacro Cuore, Rome.
  • Vitello S; Unit of Oncology, Sant'Elia Hospital, Caltanissetta.
  • Longarini R; Unit of Medical Oncology, San Gerardo Hospital, Monza.
  • Bonetti A; Unit of Medical Oncology, Mater Salutis Hospital, Legnago.
  • D'Amico M; Unit of Medical Oncology, Galliera Hospital, Genoa.
  • Di Donato S; Department of Medical Oncology Sandro Pitigliani, Prato Hospital, Istituto Toscano Tumori, Prato.
  • Granetto C; Unit of Medical Oncology, Azienda Sanitaria Ospedaliera Santa Croce e Carle, Cuneo.
  • Boni L; Clinical Trials Coordinating Center, Istituto Toscano Tumori, Firenze.
  • Falcone A; Unit of Medical Oncology 2, Polo Oncologico, Azienda Ospedaliero-Universitaria Pisana, Istituto Toscano Tumori, Pisa; Unit of Medical Oncology 2, University of Pisa, Pisa. Electronic address: alfredo.falcone@med.unipi.it.
Ann Oncol ; 26(6): 1188-1194, 2015 Jun.
Article in En | MEDLINE | ID: mdl-25712456

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Camptothecin / Colorectal Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Angiogenesis Inhibitors / Bevacizumab Type of study: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Humans / Middle aged Country/Region as subject: Europa Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2015 Document type: Article Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Camptothecin / Colorectal Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Angiogenesis Inhibitors / Bevacizumab Type of study: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Humans / Middle aged Country/Region as subject: Europa Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2015 Document type: Article Country of publication: United kingdom